Diabetes primary prevention program: New insights from data analysis of recruitment period.
Gagliardino JJ, Elgart JF, Bourgeois M, Etchegoyen G, Fantuzzi G, Ré M, Ricart JP, García S, Giampieri C, González L, Suárez-Crivaro F, Kronsbein P, Angelini JM, Martínez C, Martínez J, Ricart A, Spinedi E.
Gagliardino JJ, et al. Among authors: re m.
Diabetes Metab Res Rev. 2018 Jan;34(1). doi: 10.1002/dmrr.2943. Epub 2017 Oct 19.
Diabetes Metab Res Rev. 2018.
PMID: 28843031
Clinical Trial.
Approximately 53.7% of the OGTT showed normal values and 5.2% unknown T2D. The remaining cases showed 69.5% impaired fasting glucose, 13.6% impaired glucose tolerance, and 16.9% both impairments. ...
Approximately 53.7% of the OGTT showed normal values and 5.2% unknown T2D. The remaining cases showed 69.5% impaired fasting glucose, …